東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Toxicology and Pharmacokinetics of P...

Wu, Jie.

FindBook

Google Book

Amazon

博客來

Toxicology and Pharmacokinetics of Perfluorooctanoic Acid (PFOA).

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Toxicology and Pharmacokinetics of Perfluorooctanoic Acid (PFOA)./
作者:	Wu, Jie.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2017,
面頁冊數:	72 p.
附註:	Source: Masters Abstracts International, Volume: 79-11.
Contained By:	Masters Abstracts International79-11.
標題:	Environmental Health. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10276849
ISBN:	9780355777420

Toxicology and Pharmacokinetics of Perfluorooctanoic Acid (PFOA).
Wu, Jie.

Toxicology and Pharmacokinetics of Perfluorooctanoic Acid (PFOA). - Ann Arbor : ProQuest Dissertations & Theses, 2017 - 72 p.

Source: Masters Abstracts International, Volume: 79-11.

Thesis (M.P.H.)--Yale University, 2017.

This item must not be sold to any third party vendors.

Perfluorooctanoic acid (PFOA), a widely used synthetic chemical, is a growing public health concern. Detectable serum levels can be found in most residents of the U.S. The purpose of this thesis is to convert the environmental PFOA exposures to internal doses in a specific population and to extrapolate the internal dose into estimates of individual risk. Because exposure to PFOA is suspected to cause a number of human health effects, in order to better understand the impact of environmental PFOA exposure, this thesis first reviewed major epidemiology studies on the most frequently reported cancer and non-cancer human health effects. Though evidence remains limited and clear associations have not been established for most of the outcomes, the association between PFOA and kidney cancer is the most robust and is thus selected as the outcome of interest for this study. To evaluate exposure and effects, I then evaluated the pharmacokinetics of PFOA. It is almost completely absorbed and it is not metabolized in human, so its fate is determined by elimination. Most human studies used compartmental pharmacokinetic models to approximate that elimination, but results have been inconsistent. I next considered some of the likely reasons for that. Finally, I compared one-compartment models using pharmacokinetic parameters from different human studies, and applied them to drinking water data from the State of Colorado. This thesis demonstrates the utility of pharmacokinetic models and their dependency on the available parameters for model building.

ISBN: 9780355777420Subjects--Topical Terms:

578282
Environmental Health.

Toxicology and Pharmacokinetics of Perfluorooctanoic Acid (PFOA).
LDR:02645nmm a2200349 4500 001 2197491
005 20190923134334.5
008 200811s2017 ||||||||||||||||| ||eng d
020 $a 9780355777420
035 $a (MiAaPQ)AAI10276849
035 $a (MiAaPQ)publichealthyale:10636
035 $a AAI10276849
035 $a 2197491
040 $a MiAaPQ $c MiAaPQ
100 1 $a Wu, Jie. $3 1024842
245 1 0 $a Toxicology and Pharmacokinetics of Perfluorooctanoic Acid (PFOA).
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2017
300 $a 72 p.
500 $a Source: Masters Abstracts International, Volume: 79-11.
500 $a Publisher info.: Dissertation/Thesis.
500 $a Advisor: Borak, Jonathan.
502 $a Thesis (M.P.H.)--Yale University, 2017.
506 $a This item must not be sold to any third party vendors.
520 $a Perfluorooctanoic acid (PFOA), a widely used synthetic chemical, is a growing public health concern. Detectable serum levels can be found in most residents of the U.S. The purpose of this thesis is to convert the environmental PFOA exposures to internal doses in a specific population and to extrapolate the internal dose into estimates of individual risk. Because exposure to PFOA is suspected to cause a number of human health effects, in order to better understand the impact of environmental PFOA exposure, this thesis first reviewed major epidemiology studies on the most frequently reported cancer and non-cancer human health effects. Though evidence remains limited and clear associations have not been established for most of the outcomes, the association between PFOA and kidney cancer is the most robust and is thus selected as the outcome of interest for this study. To evaluate exposure and effects, I then evaluated the pharmacokinetics of PFOA. It is almost completely absorbed and it is not metabolized in human, so its fate is determined by elimination. Most human studies used compartmental pharmacokinetic models to approximate that elimination, but results have been inconsistent. I next considered some of the likely reasons for that. Finally, I compared one-compartment models using pharmacokinetic parameters from different human studies, and applied them to drinking water data from the State of Colorado. This thesis demonstrates the utility of pharmacokinetic models and their dependency on the available parameters for model building.
590 $a School code: 0265.
650 4 $a Environmental Health. $3 578282
650 4 $a Pharmaceutical sciences. $3 3173021
650 4 $a Public health. $3 534748
690 $a 0470
690 $a 0572
690 $a 0573
710 2 $a Yale University. $b School of Public Health. $3 1679063
773 0 $t Masters Abstracts International $g 79-11.
790 $a 0265
791 $a M.P.H.
792 $a 2017
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10276849